Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.
MAbs. 2014 Jan-Feb;6(1):130-42. doi: 10.4161/mabs.27236.
MAbs. 2014.
PMID: 24256717
Free PMC article.
Clinical Trial.
Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.
Hornig N, Kermer V, Frey K, Diebolder P, Kontermann RE, Müller D.
Hornig N, et al. Among authors: diebolder p.
J Immunother. 2012 Jun;35(5):418-29. doi: 10.1097/CJI.0b013e3182594387.
J Immunother. 2012.
PMID: 22576347
Item in Clipboard
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44.
Diebolder P, Mpoy C, Scott J, Huynh TT, Fields R, Spitzer D, Bandara N, Rogers BE.
Diebolder P, et al.
J Nucl Med. 2021 Jan;62(1):137-143. doi: 10.2967/jnumed.120.249557. Epub 2020 Jun 8.
J Nucl Med. 2021.
PMID: 32513906
Free PMC article.
Item in Clipboard
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
Bandara N, Stott Reynolds TJ, Schehr R, Bandari RP, Diebolder PJ, Krieger S, Xu J, Miao Y, Rogers BE, Smith CJ.
Bandara N, et al. Among authors: diebolder pj.
Nucl Med Biol. 2018 Jul-Aug;62-63:71-77. doi: 10.1016/j.nucmedbio.2018.06.001. Epub 2018 Jun 8.
Nucl Med Biol. 2018.
PMID: 29929115
Free PMC article.
Item in Clipboard
Aerosol-synthesized siliceous nanoparticles: impact of morphology and functionalization on biodistribution.
Diebolder P, Vazquez-Pufleau M, Bandara N, Mpoy C, Raliya R, Thimsen E, Biswas P, Rogers BE.
Diebolder P, et al.
Int J Nanomedicine. 2018 Nov 12;13:7375-7393. doi: 10.2147/IJN.S177350. eCollection 2018.
Int J Nanomedicine. 2018.
PMID: 30519021
Free PMC article.
Item in Clipboard
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA.
Dehdashti F, et al. Among authors: diebolder p.
Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13.
Breast Cancer Res Treat. 2018.
PMID: 29442264
Free PMC article.
Item in Clipboard
Translation of ceragenin affinity for bacteria to an imaging reagent for infection.
Bandara N, Li Y, Diebolder P, Mpoy C, Gu X, Khanal P, Deng S, Rogers BE, Savage PB.
Bandara N, et al. Among authors: diebolder p.
RSC Adv. 2019;9(25):14472-14476. doi: 10.1039/c9ra02226k. Epub 2019 May 8.
RSC Adv. 2019.
PMID: 32864109
Free PMC article.
Item in Clipboard
Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library.
Singh AK, Lewis CD, Boas CAWV, Diebolder P, Jethva PN, Rhee A, Song JH, Goo YA, Li S, Nickels ML, Liu Y, Rogers BE, Kapoor V, Hallahan DE.
Singh AK, et al. Among authors: diebolder p.
Clin Cancer Res. 2024 Apr 1;30(7):1293-1306. doi: 10.1158/1078-0432.CCR-23-3647.
Clin Cancer Res. 2024.
PMID: 38277241
Item in Clipboard
Cite
Cite